Bridging biological cfDNA features and machine learning approaches.

Moser T. et al.

Liquid biopsies (LBs), particularly using circulating tumor DNA (ctDNA), are expected to revolutionize precision oncology and blood-based cancer screening. Recent technological improvements, in combination with the ever-growing understanding of cell-free DNA (cfDNA) biology, are enabling the detection of tumor-specific changes with extremely high resolution and new analysis concepts beyond genetic alterations, including methylomics, fragmentomics, and nucleosomics. The interrogation of a large number of markers and the high complexity of data render traditional correlation methods insufficient. In this regard, machine learning (ML) algorithms are increasingly being used to decipher disease- and tissue-specific signals from cfDNA. Here, we review recent insights into biological ctDNA features and how these are incorporated into sophisticated ML applications.

Tags
MagMeDIP kit
Antibody

Share this article
Tweet

Published
February, 2023

Source

Bridging biological cfDNA features and machine learning approaches.

Products used in this publication

MagMeDIP Kit

5-methylcytosine (5-mC) Antibody - clone 33D3

Events

News